B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
Ingebrigtsen, Vibeke Anett, Boye, Kjetil, Tekle, Christina, Nesland, Jahn Martin, Flatmark, Kjersti, Fodstad, Øystein
Published in International journal of cancer (01.12.2012)
Published in International journal of cancer (01.12.2012)
Get full text
Journal Article
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
Tekle, Christina, Nygren, Marit Kveine, Chen, Yih-Wen, Dybsjord, Indrejit, Nesland, Jahn Marthin, Mælandsmo, Gunhild Mari, Fodstad, Øystein
Published in International journal of cancer (15.05.2012)
Published in International journal of cancer (15.05.2012)
Get full text
Journal Article
Immunoregulatory protein B7‐H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
Flem‐Karlsen, Karine, Tekle, Christina, Andersson, Yvonne, Flatmark, Kjersti, Fodstad, Øystein, Nunes‐Xavier, Caroline E.
Published in Pigment cell and melanoma research (01.09.2017)
Published in Pigment cell and melanoma research (01.09.2017)
Get full text
Journal Article
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis
Facon, Thierry, Moreau, Philippe, Baker, Ross, Min, Chang-Ki, Leleu, Xavier, Mohty, Mohamad, Karlin, Lionel, Armstrong, Nicole M, Tekle, Christina, Schwab, Sandrine, Risse, Marie-Laure, Martin, Thomas
Published in Haematologica (Roma) (01.02.2024)
Published in Haematologica (Roma) (01.02.2024)
Get full text
Journal Article
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation
Liu, Hao, Tekle, Christina, Chen, Yih-Wen, Kristian, Alexandr, Zhao, Yuhua, Zhou, Ming, Liu, Zixing, Ding, Yan, Wang, Bin, Mælandsmo, Gunhild Mari, Nesland, Jahn Marthin, Fodstad, Oystein, Tan, Ming
Published in Molecular cancer therapeutics (01.06.2011)
Published in Molecular cancer therapeutics (01.06.2011)
Get full text
Journal Article
Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
Nunes-Xavier, Caroline E, Karlsen, Karine Flem, Tekle, Christina, Pedersen, Cathrine, Øyjord, Tove, Hongisto, Vesa, Nesland, Jahn M, Tan, Ming, Sahlberg, Kristine Kleivi, Fodstad, Øystein
Published in Oncotarget (09.02.2016)
Published in Oncotarget (09.02.2016)
Get full text
Journal Article
Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells
Giovannetti, Elisa, Lemos, Clara, Tekle, Christina, Smid, Kees, Nannizzi, Sara, Rodriguez, José A, Ricciardi, Simona, Danesi, Romano, Giaccone, Giuseppe, Peters, Godefridus J
Published in Molecular pharmacology (01.04.2008)
Published in Molecular pharmacology (01.04.2008)
Get full text
Journal Article
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY
Pektas, Ozgur, Navaratnam, Prakash, Rajput, Tanvi, Frıedman, Howard S., Demırkır, Ece, Tekle, Christina, Lın, Peggy
Published in Hematology, Transfusion and Cell Therapy (01.10.2023)
Published in Hematology, Transfusion and Cell Therapy (01.10.2023)
Get full text
Journal Article
P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA‐HIGH‐RISK CYTOGENETICS: ICARIA‐MM AND IKEMA SUBGROUP ANALYSIS
Moreau, Philippe, Perrot, Aurore, Dimopoulos, Meletios A., Martin, Thomas, Facon, Thierry, Eduardo Capra, Marcelo, Beksac, Meral, Armstrong, Nicole, Dubin, Franck, Macé, Sandrine, Risse, Marie‐Laure, Tekle, Christina, Klippel, Zandra, Richardson, Paul
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P968: ALLOCATION AND VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM IN THE ICARIA‐MM AND IKEMA STUDIES
Perrot, Aurore, Richardson, Paul, Mikhael, Joseph, Martin, Thomas G., Beksac, Meral, Spicka, Ivan, Eduardo Capra, Marcelo, D’agostino, Mattia, Sonneveld, Pieter, Bisht, Kamlesh, Fukao, Taro, Zhang, Rick, Tada, Keisuke, Tekle, Christina, Macé, Sandrine, Klippel, Zandra, Velde, Helgi, Moreau, Philippe
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Pharmacological aspects of the enzastaurin-pemetrexed combination in non-small cell lung cancer (NSCLC)
Giovannetti, Elisa, Honeywell, Richard, Hanauske, Axel R, Tekle, Christina, Kuenen, Bart, Sigmond, Jennifer, Giaccone, Giuseppe, Peters, Godefridus J
Published in Current drug targets (01.01.2010)
Published in Current drug targets (01.01.2010)
Get more information
Journal Article
Isatuximab Plus Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma in Real-Life Context in France: IMAGE Subgroup Analysis Based on Prior Lines of Therapy and Refractory Status
Decaux, Olivier, Lafore, Radhia, Iaquinta, Daniel, Tekle, Christina, Leleu, Xavier
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes for Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Leleu, Xavier, Delea, Thomas, Guyot, Patricia, Moynahan, Aaron, Singh, Erin, Tekle, Christina, Lin, Peggy L
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
MM-146: IONA-MM: A Prospective, Non-Interventional, Multinational, Observational Study with Isatuximab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Tekle, Christina, Barnes, Yvonne, Sievert, Mark
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Get full text
Journal Article
Isatuximab Plus Carfilzomib and Dexamethasone in Patients with Early Versus Late Relapsed Multiple Myeloma: Ikema Subgroup Analysis
Facon, Thierry, Moreau, Philippe, Baker, Ross, Pour, Ludek, Min, Chang-Ki, Leleu, Xavier, Mohty, Mohamad, Karlin, Lionel, Rawlings, Andreea, Tekle, Christina, Schwab, Sandrine, Risse, Marie-Laure, Martin, Thomas
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Ikema Subgroup Analysis By Number of Prior Lines of Treatment
Capra, Marcelo, Martin, Thomas, Moreau, Philippe, Martinez, Gracia, Oriol, Albert, Koh, Youngil, Quach, Hang, Yong, Kwee, Rawlings, Andreea, Tekle, Christina, Macé, Sandrine, Risse, Marie-Laure, Spicka, Ivan
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Isatuximab Plus Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM) in Real-Life Context in France: IMAGE Subgroup Analysis Based on Prior Lines of Therapy and Refractory Status in Anti-CD38-Naïve Population
Leleu, Xavier, Fontan, Jean, Perrot, Aurore, Karlin, Lionel, Touzeau, Cyrille, Schulmann, Samantha, Manier, Salomon, Belhadj Merzoug, Karim, Trebouet, Adrien, Zunic, Patricia, Schiano De Colella, Jean Marc, Tekle, Christina, Gaucher, Marianne, Decaux, Olivier
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article